These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24010910)

  • 1. Positron emission tomography/computed tomography in melanoma.
    Bourgeois AC; Chang TT; Fish LM; Bradley YC
    Radiol Clin North Am; 2013 Sep; 51(5):865-79. PubMed ID: 24010910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node.
    Wagner T; Meyer N; Zerdoud S; Julian A; Chevreau C; Payoux P; Courbon F
    Br J Dermatol; 2011 Jun; 164(6):1235-40. PubMed ID: 21332457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB; Soo V; Kraas J; Shen P; Levine EA
    Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
    Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
    Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desmoplastic malignant melanoma evaluated with 18F-fluorodeoxyglucose positron emission tomography-computed tomography and sentinel lymph node biopsy.
    Jung JY; Roh MR; Chung HJ; Chung KY
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):126-7. PubMed ID: 18181996
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluorodeoxyglucose-positron emission tomography imaging versus sentinel node biopsy in the primary staging of melanoma patients.
    Longo MI; Lázaro P; Bueno C; Carreras JL; Montz R
    Dermatol Surg; 2003 Mar; 29(3):245-8. PubMed ID: 12614417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
    Klein M; Freedman N; Lotem M; Marciano R; Moshe S; Gimon Z; Chisin R
    Nuklearmedizin; 2000; 39(3):56-61. PubMed ID: 10834191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerations on 18FDG PET/CT and sentinel lymph node biopsy in AJCC stages I and II of melanoma.
    Veronesi G; Ravaioli GM; Lambertini M; Zannetti G; Diodato S; Gardini A; Patrizi A; Fanti S; Dika E
    G Ital Dermatol Venereol; 2020 Dec; 155(6):784-786. PubMed ID: 29998716
    [No Abstract]   [Full Text] [Related]  

  • 9. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of FDG PET-CT in cutaneous melanoma].
    Nicol I; Chuto G; Gaudy-Marqueste C; Brenot-Rossi I; Grob JJ; Richard MA
    Bull Cancer; 2008 Nov; 95(11):1089-101. PubMed ID: 19036682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for lymphoscintigraphy and F18 FDG PET scans in melanoma.
    Uren RF; Howman-Giles R; Chung D; Thompson JF
    J Surg Oncol; 2011 Sep; 104(4):405-19. PubMed ID: 21858836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
    Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
    Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of FDG-PET-CT is limited in initial staging of nodal metastasis for thin cutaneous melanoma.
    Cheng D; McNicoll CF; Kirgan D; Jones MS; Rivera MR; Doyle GM; De Guzman MD; Baynosa J; St Hill CR
    Am J Surg; 2021 Apr; 221(4):737-740. PubMed ID: 32354604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [PET scanning for malignant melanoma and positive sentinel node diagnostics].
    Horn J; Sjøstrand H; Lock-Andersen J; Loft A
    Ugeskr Laeger; 2010 Apr; 172(15):1126-30. PubMed ID: 20427004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Futility of positron emission tomography and other modalities in the initial radiographic screening of patients with melanoma.
    Miranda EP
    Arch Surg; 2006 Oct; 141(10):1050. PubMed ID: 17043288
    [No Abstract]   [Full Text] [Related]  

  • 16. Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit.
    Constantinidou A; Hofman M; O'Doherty M; Acland KM; Healy C; Harries M
    Melanoma Res; 2008 Feb; 18(1):56-60. PubMed ID: 18227709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma imaging with highly specific PET probes: ready for prime time?
    Minn H; Vihinen P
    J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
    [No Abstract]   [Full Text] [Related]  

  • 18. PET/Computed Tomography and Patient Outcomes in Melanoma.
    Rohren EM
    PET Clin; 2015 Apr; 10(2):243-54. PubMed ID: 25829089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma.
    Bikhchandani J; Wood J; Richards AT; Smith RB
    Head Neck; 2014 Sep; 36(9):1313-6. PubMed ID: 23956077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence.
    Abbott RA; Acland KM; Harries M; O'Doherty M
    Melanoma Res; 2011 Oct; 21(5):446-9. PubMed ID: 21849913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.